Dorzox T Eye Drop

Dorzox T Eye Drop is a prescription ophthalmic solution manufactured by Cipla Limited, combining two active ingredients—dorzolamide (a carbonic anhydrase inhibitor) and timolol (a beta-blocker)—to effectively lower intraocular pressure (IOP) in patients diagnosed with glaucoma or ocular hypertension. Dorzolamide works by reducing the production of aqueous humor in the eye through inhibition of carbonic anhydrase II, while timolol decreases aqueous humor formation by blocking beta-adrenergic receptors in the ciliary body. This dual-action formulation provides superior IOP reduction compared to single-agent therapies, making it an essential treatment for patients whose pressure levels remain elevated despite monotherapy. For those requiring alternative beta-blocker options, Iobet Eye Drop offers betaxolol as another effective choice, while patients using dorzolamide alone may find Dorzox Eye Drop suitable for less severe cases.

Dosage & Usage

The standard dosage for Dorzox T Eye Drop is one drop in the affected eye(s) twice daily, approximately 12 hours apart. Wash your hands thoroughly before administration, tilt your head back, gently pull down the lower eyelid to create a small pocket, and instill one drop without touching the dropper tip to your eye or any surface to prevent contamination. Close your eye gently for 1-2 minutes and apply light pressure to the inner corner near the nose to minimize systemic absorption. If you use other eye medications, wait at least 10 minutes between applications. The maximum recommended dose is one drop twice daily per eye; exceeding this dosage does not enhance efficacy and may increase the risk of side effects. Do not discontinue use without consulting your ophthalmologist, as stopping suddenly can cause IOP to rise rapidly.

Who Is It For?

Dorzox T Eye Drop is prescribed for adults with open-angle glaucoma or ocular hypertension who require combination therapy to adequately control intraocular pressure. This medication is particularly beneficial for patients who have not responded sufficiently to single-agent treatment or who need more aggressive pressure reduction to prevent optic nerve damage and vision loss. Contraindications include bronchial asthma, severe chronic obstructive pulmonary disease (COPD), sinus bradycardia, heart block, overt cardiac failure, and severe kidney disease. Timolol's beta-blocking effects can worsen respiratory conditions and cardiac function, while dorzolamide is cleared renally and may accumulate in kidney impairment. Patients with sulfonamide allergies should avoid this product due to dorzolamide's sulfonamide structure. Pregnant or breastfeeding women should discuss risks versus benefits with their healthcare provider, and elderly patients may require closer monitoring. Those managing post-surgical inflammation might consider Cyclomune Eye Drop for dry eye symptoms that sometimes accompany glaucoma therapy.

Why Buy From SafeRxPills?

SafeRxPills offers genuine WHO-GMP certified Dorzox T Eye Drop with discreet delivery to the USA, UK, Australia, and Canada in 7-14 business days. All orders arrive in plain, unmarked packaging to protect your privacy, and our licensed pharmacy ensures every product meets stringent international quality standards. Purchase your prescription eye care medications with confidence from SafeRxPills.